VTRS
US EQUITY
Health Care
Pharmaceuticals
CIK: 1792044
Viatris (VTRS) Quant Factor Diagnostic & Fair Value Model
Viatris (Ticker: VTRS) is listed in the Health Care sector (Pharmaceuticals). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$18.00
-2.60%
Latest Close (2026-10-23)
Market Cap: $20.67B
P/E Ratio: -
Momentum Strength
3M / 12M
+2.04%
1M: +3.33%
12M: +72.91%
Quality (ROE)
Point-in-Time
-
Trailing Return on Equity
Technical Trend
RSI 14
55.2
SMA50: $17.19
SMA200: $15.75
Valuation Multiplier
Trailing
-
Pre-Profit / Negative TTM
📊
Valuation & Multi-Factor Diagnostic
Pre-Profit / Negative TTM
VTRS has negative or near-zero trailing GAAP earnings over the trailing twelve months.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 4/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1792044 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-06 | $3.76B | - | $770.10M | $-0.10 |
| 10-Q | 2025-12-31 | 2026-08-06 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-06 | $3.58B | - | $755.20M | $0.00 |
| 10-Q | 2026-03-31 | 2026-05-07 | $3.52B | - | $388.30M | $0.15 |
| 10-Q | 2025-03-31 | 2026-05-07 | $3.25B | - | $535.50M | $-2.55 |
| 10-K | 2025-12-31 | 2026-02-26 | $14.30B | - | $2.32B | $-3.00 |
| 10-K | 2024-12-31 | 2026-02-26 | $14.74B | - | $2.30B | $-0.53 |
| 10-K | 2023-12-31 | 2026-02-26 | $15.43B | - | $2.90B | $0.05 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Viatris (VTRS) valuation multiples, momentum factors, and point-in-time filing conventions.
How should VTRS's current valuation multiple be interpreted? ↓
VTRS trades at a trailing P/E of -x within the Health Care sector (pre-profit / negative ttm). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are VTRS's key momentum and technical factor indicators? ↓
As of the latest close, VTRS shows a 1-month return of +3.33%, 3-month return of +2.04%, and 12-month return of +72.91%, with a 14-day RSI of 55.2. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for VTRS? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can VTRS be incorporated into systematic factor models? ↓
VTRS can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.